A detailed history of Tfb Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tfb Advisors LLC holds 3,188 shares of NVO stock, worth $340,829. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,188
Previous 3,276 2.69%
Holding current value
$340,829
Previous $467,000 18.84%
% of portfolio
0.11%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$119.07 - $145.42 $10,478 - $12,796
-88 Reduced 2.69%
3,188 $379,000
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $83,933 - $100,486
684 Added 26.39%
3,276 $467,000
Q1 2024

May 03, 2024

BUY
$102.11 - $135.92 $264,669 - $352,304
2,592 New
2,592 $332,000
Q2 2023

Jul 18, 2023

BUY
$155.98 - $172.65 $198,250 - $219,438
1,271 New
1,271 $205,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $241B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tfb Advisors LLC Portfolio

Follow Tfb Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfb Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfb Advisors LLC with notifications on news.